The primary outcome measure is normalized T1-weighted signal intensity. One month after injection [clinicaltrials_resource:5d1947e9b816a10910a0c3b6867fc252]
Contrast Agent
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
The primary outcome measure is normalized T1-weighted signal intensity. One month after injection [clinicaltrials_resource:5d1947e9b816a10910a0c3b6867fc252]
Contrast Agent
Bio2RDF identifier
5d1947e9b816a10910a0c3b6867fc252
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5d1947e9b816a10910a0c3b6867fc252
measure [clinicaltrials_vocabulary:measure]
The primary outcome measure is normalized T1-weighted signal intensity.
time frame [clinicaltrials_vocabulary:time-frame]
One month after injection
description
Contrast Agent
identifier
clinicaltrials_resource:5d1947e9b816a10910a0c3b6867fc252
title
The primary outcome measure is ...... ity. One month after injection
@en
type
label
The primary outcome measure is ...... 947e9b816a10910a0c3b6867fc252]
@en